Skip to content

Novo

by PathAI, Inc.

510(k) K212361

Novo is a medical device (FDA Class II; FDA product code QKQ, Digital Pathology Image Viewing And Management Software) made by PathAI, Inc., cleared under FDA 510(k) K212361 on 11 Aug 2022, active as of 11 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 11 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 11 Oct 2026.

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK212361 Date11 Aug 2022ClearedStatusActive

Official records

From the FDA record

Received by the FDA
30 Jul 2021
FDA decision
11 Aug 2022 (Substantially Equivalent)
FDA review time
377 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K212361 (openFDA), as read on 11 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
QKQ
Device class
Class II
Regulation
21 CFR Part 864.3700
Advisory committee
Pathology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code QKQ (Digital Pathology Image Viewing And Management Software).

Other devices from PathAI, Inc.

  • AISight Dx 11124001

    Class II
  • AISight Dx

    Class A